{"SPADE_N_06049": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2023/0416797 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1", "Patent Type": "Patent Application", "Publication Date": "2023-12-28", "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1", "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE", "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."}], "Sequence Information": {"SPADE ID": "SPADE_N_06049", "Sequence": "MNKELNALTNPIDEKELEQILGGGNGVIKTISHECHMNTWQFIFTCCS", "Sequence Length": 48, "Peptide Name": "Sequence 17 from US 20230416797", "Source": "Butyrivibrio fibrisolvens", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "EIN", "Absent Amino Acids": "ORUY", "Basic Residues": 5, "Acidic Residues": 6, "Hydrophobic Residues": 17, "Polar Residues": 23, "Positive Residues": 5, "Negative Residues": 6, "Mass": 5409.14, "PI": 5.01, "Net Charge": -1, "Hydrophobicity": -0.24, "Similar Sequences": [{"SPADE_ID": "SPADE_N_00005", "Similarity": 1.0, "Sequence": "GNGVIKTISHECHMNTWQFIFTCCS"}, {"SPADE_ID": "SPADE_N_00026", "Similarity": 0.875, "Sequence": "GNGVLKTISHECNMNTWQFLFTCC"}, {"SPADE_ID": "SPADE_N_15253", "Similarity": 0.8695652173913043, "Sequence": "GNGVLKTISHECNMNWQFLFTCC"}]}}}